Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)
Others
Ratios

BioNexus Gene Lab (BGLC) Income from Continuing Operations (2018 - 2025)

Historic Income from Continuing Operations for BioNexus Gene Lab (BGLC) over the last 8 years, with Q3 2025 value amounting to -$708991.0.

  • BioNexus Gene Lab's Income from Continuing Operations rose 4730.14% to -$708991.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.3 million, marking a year-over-year decrease of 16676.32%. This contributed to the annual value of -$1.6 million for FY2024, which is 3846.25% up from last year.
  • BioNexus Gene Lab's Income from Continuing Operations amounted to -$708991.0 in Q3 2025, which was up 4730.14% from -$616172.0 recorded in Q2 2025.
  • Over the past 5 years, BioNexus Gene Lab's Income from Continuing Operations peaked at $671809.0 during Q4 2021, and registered a low of -$2.6 million during Q3 2023.
  • For the 5-year period, BioNexus Gene Lab's Income from Continuing Operations averaged around -$263310.9, with its median value being -$63621.0 (2024).
  • Examining YoY changes over the last 5 years, BioNexus Gene Lab's Income from Continuing Operations showed a top increase of 77148.37% in 2023 and a maximum decrease of 327100.17% in 2023.
  • BioNexus Gene Lab's Income from Continuing Operations (Quarter) stood at $671809.0 in 2021, then tumbled by 107.79% to -$52349.0 in 2022, then surged by 771.48% to $351515.0 in 2023, then plummeted by 197.1% to -$341331.0 in 2024, then plummeted by 107.71% to -$708991.0 in 2025.
  • Its last three reported values are -$708991.0 in Q3 2025, -$616172.0 for Q2 2025, and -$623327.0 during Q1 2025.